A Rational Grant of Micronutrients as a Way to Improve Quality of Life of Climacteric Syndrome Patients

Ших, Е. В.; Grebenshhikova, L. Y.

doi:10.21518/2079-701x-2017-13-166-171

Cited by 5 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Применение МЕНСЕ ® в качестве монотерапии пациентками перименопаузального возраста приводит к снижению индекса Купермана в среднем в 1,7 раза, более выраженное снижение (почти в 2 раза) наблюдается у пациенток с изначально легким течением КС [29].…”

Section: аскорбиновая кислота (витамин с)unclassified

“…В результате дотации микронутриентов комплексное воздействие МЕНСЕ ® (в качестве монотерапии) на организм женщины заключается в стимуляции собственных резервов организма по поддержанию гормонального баланса и нормализации психоэмоционального состояния, что клинически выражается в снижении частоты приливов и улучшении качества жизни пациенток [29].…”

Section: аскорбиновая кислота (витамин с)unclassified

See 1 more Smart Citation

Climacteric syndrome. A nutritional approach to treatment

Saprykina¹,

Narimanova²,

Ibragimova³

2020

Russian Journal of Woman and Child Health

View full text Add to dashboard Cite

Female sex hormones are of crucial importance for a woman’s life. Almost all women over 40 irrespective of their origin or social status begin to experience physical, psychologic, and emotional problems. Menopause hormone therapy (MHT) is considered the most effective option to improve various symptoms of climacteric syndrome. Non-hormonal treatment can be an alternative to MHT to relieve the symptoms of climacteric symptoms in pre- and postmenopausal women, in particular, in contraindications or reluctance to take MHT. The paper addresses recent findings on the effects of soy isoflavones, β-alanine, tryptophan, and vitamins on tissues and the quality of life of pre- and postmenopausal women. Mense® (JC «Akvion»), a biologically active supplement that contains phytoestrogens, vitamins, and amino acids, is characterized by a variety of protective effects in pre- and postmenopausal periods. This biologically active supplement can be recommended for women with the symptoms of climacteric syndrome as a pretreatment during the screening before prescribing MHT, a dietary modification in contraindications or refusal of MHT, and/or an effective component of the complex treatment for climacteric syndrome.KEYWORDS: perimenopause, postmenopause, non-hormonal treatment, menopause hormone therapy, vasomotor symptoms, phytoestrogens, vitamins.FOR CITATION: Saprykina L.V., Narimanova M.R., Ibragimova D.M. Climacteric syndrome. A nutritional approach to treatment. Russian Journal of Woman and Child Health. 2020;3(3):189–193. DOI: 10.32364/2618-8430-2020-3-3-189-193.

show abstract

Section: аскорбиновая кислота (витамин с)unclassified

Climacteric syndrome. A nutritional approach to treatment

Saprykina¹,

Narimanova²,

Ibragimova³

2020

Russian Journal of Woman and Child Health

View full text Add to dashboard Cite

show abstract

Alternative and complementary correction of menopausal disorders

Averkova

Yakushevskaya

2022

Medicinskij sovet

View full text Add to dashboard Cite

Menopause, defined as the cessation of menses for 12 months and more, is a multidimensional evolutionary process, which has a considerable impact on the women’s quality of life and the risk of development of age-associated pathology. 47 million of women around the world enter the menopausal period each year. The menopause onset age is the most important factor which determines the woman health status and, to a large extent, both the risk of morbidity and mortality. Menopause may be induced by a surgical intervention, chemotherapy, and radiation therapy. Post-menopause period accounts for about onethird of a woman’s life and is quite often accompanied by the development of different symptoms associated with estrogen deficiency. Vasomotor symptoms (VMS) are primarily referred to the initial manifestations of the climacteric syndrome. VMS frequency prevails within the two-year period immediately before and after the last menstruation. In some patients, hot flashes can begin long before (10 years prior to) the menopause and persist for a long time. Night sweats, dysphoric disorders, urogenital atrophy / urination disorders, sexual (decreased libido) and cognitive changes, and sleep disturbances are often observed due to the estrogen deficiency. MHT should be considered as a first line therapeutic intervention for the correction of climacteric disorders and prevention of age-associated pathology in women with premature ovarian failure and in menopausal women under the age of 60. For patients who are wary of hormonal therapy or have absolute / relative contradictions to the use of MHT, alternative methods of menopausal disorders correction, which include nonpharmacological and pharmacological non-hormonal drugs with different degrees of efficiency and safety should be considered. Phytoestrogens have confidently filled a niche of alternative therapy for the treatment of menopausal disorders.

show abstract

Psycho-emotional state of women during the perimenopausal transition

Markova

Хашукоева

2023

Medicinskij sovet

View full text Add to dashboard Cite

A woman’s health during the perimenopausal transition is not irrelevant because of the risk zone in which this category of women falls. Mature patients often have complaints associated with the menopausal syndrome. The increase in life expectancy of women, their active lifestyle that they want to maintain, which is not always possible due to the presence of a number of adverse factors such as the environment, stress factors, the presence of chronic diseases that tend to frequent exacerbations, all this aggravates the overall condition of women and primarily has a negative impact on their psycho-emotional health. The menopausal syndrome, which can debut during the perimenopausal transition, further complicates the woman’s condition. The job of a specialist gynaecologist is to help and manage these patients. It would seem that there is no question: the clinical guidelines and protocols are clearly prescribed algorithms for the management and therapy of such patients, where it is stated in black and white about the prescription of menopausal hormone therapy, which is pathogenetic and justified in the development of the menopausal syndrome and the complaints associated with it. But the prescription of this therapy is associated with a set of risks and side effects. Non-hormonal therapy is a good alternative in the treatment of menopausal disorders, given that hormonal treatment is contraindicated in a number of women. This article presents a cross-section of the literature data on the results of prescribing a dietary supplement MENSE® (Aquion JSC, Russia) in women with psycho-emotional tension during menopause. MENSE® complex contains an impressive range of components (β-alanine, 5-hydroxytryptophan, phytoestrogens – soy isoflavones, B vitamins, folic acid, vitamins E and C) favorably affecting the female body and improves the quality of her life during perimenopause. This complex can be recommended for patients with menopausal syndrome as an effective therapeutic agent for the period of selection of menopausal hormonal therapy or the presence of contraindications to it. MENSE® is an effective complex for improving the quality of life of perimenopausal women against the background of psycho-emotional conditions.

show abstract

A Rational Grant of Micronutrients as a Way to Improve Quality of Life of Climacteric Syndrome Patients

Cited by 5 publications

References 1 publication

Climacteric syndrome. A nutritional approach to treatment

Climacteric syndrome. A nutritional approach to treatment

Alternative and complementary correction of menopausal disorders

Psycho-emotional state of women during the perimenopausal transition

Contact Info

Product

Resources

About